GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,165.00p
   
  • Change Today:
      24.00p
  • 52 Week High: 2,198.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,076.08m
  • Volume: 13,157,222
  • Market Cap: £88,247m
  • RiskGrade: 129
  • Beta: 0.84

Latest ShareCast News

China's CDE accepts GSK's regulatory filing for RSV vaccine

By Iain Gilbert

Date: Tuesday 10 Feb 2026

(Sharecast News) - Drugmaker GSK said on Tuesday that China's Center for Drug Evaluation has accepted its regulatory filing for Arexvy, its recombinant, adjuvanted respiratory syncytial virus vaccine, for the prevention of lower respiratory tract disease in adults aged 60 and over.

GSK ShareCast News

JP Morgan raises target price on GSK 09-Feb-2026 ShareCast
Director dealings: GSK chairman raises stake 06-Feb-2026 ShareCast
EU gives GSK's Nucala green light for use in unc... 06-Feb-2026 ShareCast
GSK sees slower sales growth in 2026 as patent l... 04-Feb-2026 ShareCast
GSK to cut up to 350 R&D jobs across UK, US 02-Feb-2026 ShareCast

GSK Regulatory News

Director/PDMR Shareholding 11-Feb-2026 15:30 RNS
Director/PDMR Shareholding 11-Feb-2026 15:30 RNS
Director/PDMR Shareholding 11-Feb-2026 15:30 RNS
Director/PDMR Shareholding 11-Feb-2026 15:30 RNS
China CDE accepts Arexvy adults 60+ application 10-Feb-2026 07:00 RNS

GSK Newspaper Links

GSK beats City expectations but forecasts softer... 04-Feb-2026 Times
GSK looking at future cost savings and manufactu... 02-Feb-2026 Times
GlaxoSmithKline scraps sale of old drugs 05-Dec-2014 Telegraph
Glaxo sharpens axe to save £1bn as insurers and ... 01-Dec-2014 The Independent
GSK to cut hundreds of US jobs 01-Dec-2014 Telegraph

GSK Tips & Analysis

Questor :GlaxoSmithKline 16-Apr-2014 Telegraph
Questor:GlaxoSmithKline 06-Oct-2011 Telegraph
Questor:GlaxoSmithKline 11-Aug-2011 Telegraph
Questor tip: GlaxoSmithKline 28-Jul-2011 Telegraph
Investment Column: GlaxoSmithKline 27-Jul-2011 The Independent

GSK News Wires

FDA Approves Promacta(R) (Eltrombopag), the Firs... 20-Nov-2008 PR Newswire
Study Found That Long Term Use of Advair Diskus(... 29-Oct-2008 PR Newswire
GlaxoSmithKline to Acquire Genelabs Technologies... 29-Oct-2008 PR Newswire
A New Interactive Consumer Experience Highlighti... 28-Sep-2007 PR Newswire
AUDIO from Medialink and GlaxoSmithKline: A New ... 28-Sep-2007 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 2,165.00p
Change Today 24.00p
% Change 1.12 %
52 Week High 2,198.00p
52 Week Low 1,264.00p
Volume 13,157,222
Shares Issued 4,076.08m
Market Cap £88,247m
Beta 0.84
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 13
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 19-Feb-26 13-Nov-25
Paid 09-Apr-26 08-Jan-26
Amount 18.00p 16.00p

Trades for 13-Feb-2026

Time Volume / Share Price
12:27 1,997,424 @ 2,170.00p
12:27 1,997,424 @ 2,170.00p
17:05 6,081 @ 2,165.00p
16:35 9,028 @ 2,165.00p
16:35 972 @ 2,165.00p

GSK Key Personnel

CEO Luke Miels

Top of Page